【正文】
載陳建志、王國(guó)肇二人與設(shè)立於美國(guó)之美商 APLUS 公司已成年之工程人員 , 均明知並未取得美商微晶片公司許可 ,仍基於共同意圖銷售之概括犯意,自八十三 年七月間起,由太欣公司與 APLUS公司共同 以還原工程( Reverse Engineering)之方 式,抄襲美商微晶片公司上開 PIC16C5X系列微程式中之PIC16C56微程式 ,擅自連續(xù)重 製成 STK56C110微控制晶片。乃理由並未舉出上訴人等如何以還原工程之方式抄襲 PIC 16C56 微程式之依據(jù),已有失所依據(jù)之可議。 藥品與農(nóng)化產(chǎn)品申請(qǐng)上市所提交之尚未公開測(cè)試資訊(一) ? Article . Members, when requiring, as a condition of approving the marketing of pharmaceutical or of agricultural chemical products which utilise new chemical entities, the submission of undisclosed test or other data, the origination of which involves a considerable effort, shall protect such data against unfair mercial use. ? 營(yíng)業(yè)秘密法第九條第一項(xiàng):「公務(wù)員因承辦公務(wù)而知悉或持有他人之營(yíng)業(yè)秘密者,不得使用或無(wú)故洩漏之。」 農(nóng)化產(chǎn)品與藥品申請(qǐng)上市所提交之尚未公開測(cè)試資訊(二) ? In addition, Members shall protect such data against disclosure, except where necessary to protect the public, or unless steps are taken to ensure that the data are protected against unfair mercial use.